Two sera obtained from four healthy blood donors, which caused non-A, non-B post-transfusion hepatitis in two recipients, were experimentally inoculated into nine marmosets. Three of seven marmosets developed acute hepatitis characterized by the elevation of serum concentrations of glutamic pyruvic
Transmission of human non-a, non-b hepatitis to chimpanzees following failure to transmit gb agent hepatitis
β Scribed by Edward Tabor; Milton April; Robert J. Gerety; David A. Peterson; Leonard B. Seeff
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 384 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Two colonyβborn infant chimpanzees were inoculated with documented infectious serum containing the GB agent. Serum aminotransferase levels remained within normal limits in weekly serum samples, and no abnormalities were detected in weekly liver biopsy specimens. Each of these chimpanzees was subsequently inoculated with serum containing an agent of human nonβA, nonβB hepatitis. Each developed nonβA, nonβB hepatitis characterized by elevation of serum aminotransferase levels and histopathologic changes in liver biopsy specimens. Thus, the chimpanzee appears not to be susceptible to the GB agent, and prior inoculation with this agent does not appear to confer immunity to subsequent infection with human nonβA, nonβB hepatitis.
π SIMILAR VOLUMES
To further investigate the specificity of the monoclonal antibodies (48-1 and S-1) associated with non-A, non-B hepatitis, extensive immunofluoreecence studies were performed on liver biopsy specimens from chimpanzees with experimental hepatitis A, B, non-A, non-B or 6, or from normal chimpanzees. B
Convalescent phase non-A, non-B (NANB) human and chimpanzee sera were utilized in a solidphase radioimmunoassay (RIA) in a n attempt to identify a specific NANB antigen in human plasma, plasma-derived pellets and NP-40 disrupted pellets proven to transmit NANB infection to chimpanzees. RIA reactivit
An enzyme-linked immunosorbent assay (ELISA) was developed based on sera from patients convalescent from non-A, non-B hepatitis and haemophilia A patients who had been frequently treated with commercial blood products. Using this ELISA, an antigen was detected which appears to be related to non-A, n